Quarterly Result4 Jul 2025, 06:44 pm
Metropolis Healthcare Q1FY26 Business Update: 23% Revenue Growth, Debt-Free Balance Sheet
AI Summary
Metropolis Healthcare Ltd. has provided a business update for Q1FY26, highlighting an approximate 23% Y-o-Y revenue growth, including revenues from Core Diagnostics, Scientific Pathology, Agra, and Dr. Ahuja’s Pathology & Imaging Center. Post-acquisition, Core has moved to a single-digit positive margin trajectory. Specialty revenues have grown by approximately 35% on a Y-o-Y basis. The TruHealth Wellness and Specialty segments recorded Y-o-Y growth of ~20% and ~15%, respectively. The company remains debt-free, and EBITDA for the current quarter improved on a Q-o-Q basis.
Key Highlights
- Approx. 23% Y-o-Y revenue growth in Q1FY26
- Core Diagnostics moved to single-digit positive margin trajectory post-acquisition
- Specialty revenues grew by approx. 35% on a Y-o-Y basis
- TruHealth Wellness and Specialty segments recorded Y-o-Y growth of ~20% and ~15%, respectively
- Company remains debt-free
- EBITDA for the current quarter improved on a Q-o-Q basis